An SSRI class interaction is any supplement pattern that overlaps with selective serotonin reuptake inhibitor medications closely enough that the platform pauses activation pending prescriber confirmation. The category covers serotonergic precursors, certain herbal extracts with antidepressant-adjacent activity, and bleeding-adjacent supplements that share a side-effect profile with SSRI-related platelet effects.
Why the class is treated as a unit
SSRIs differ in their individual receptor and enzyme footprints, but they share enough mechanism that the platform applies the same screening logic across the class — citalopram, escitalopram, fluoxetine, paroxetine, sertraline, and the related set. A supplement that meaningfully overlaps one member is treated as overlapping the class until prescriber input clarifies the specific medication.
Supplements most commonly flagged
The platform flags serotonergic precursors and antidepressant-adjacent botanicals against an SSRI prescription, including 5-HTP, tryptophan, St. John's Wort, and concentrated saffron extracts. See serotonergic interaction for the symptom-escalation rules that apply across this group.
A second flag covers bleeding-adjacent supplements. SSRIs themselves can shift platelet function, and adding ginkgo biloba, garlic extract, high-dose omega-3, or nattokinase can produce additive bruising or bleeding tendency.
What an SSRI flag changes
A flagged pair holds the supplement in a non-activated state until the user confirms a prescriber conversation. The platform does not adjust prescriptions and does not suggest dose changes on either side; it provides a question template the user can take to the prescriber or pharmacist.
For users building a first roster, the pillar overview at supplement stack mistakes to avoid covers why bundling several flagged supplements into one stack change is harder to read than staggered single-compound moves.
Discontinuation and transition periods
SSRIs have varying clearance windows after stopping. A flagged supplement does not automatically reactivate the day the prescription stops; the platform extends the hold across the prescription's wash-out window so that a residual serotonergic load is not added to a tapering plasma level.
What the flag preserves
The relevant record is the specific product label, any standardized extract content, the medication class, and whether the overlap is serotonergic, bleeding-adjacent, or low-confidence.
Limits of the screen
Published data on supplement plus SSRI pairs is denser for some combinations than others. The platform marks low-confidence pairs explicitly rather than treating them as equivalent to well-studied pairs, and a missing flag is not proof of safety. The screen is a starting point for the prescriber conversation, not a final clearance.
How this appears in Unfair
An SSRI prescription in the user profile triggers a class-wide screen across active stacks. Matched serotonergic and bleeding-adjacent supplements are held with a clinician-question template pre-filled, and the screen re-runs after any prescription change.
Clinical safety note
Symptoms suggestive of serotonin toxicity are outside the scope of a glossary entry or supplement journal.